Department of Pharmacology and Toxicology, American University of Beirut Faculty of Medicine, PO Box 11-0236, Riad El Solh, Beirut 1107 2020, Lebanon.
J Clin Pharmacol. 2012 Dec;52(12):1806-14. doi: 10.1177/0091270011428986. Epub 2011 Dec 15.
The purpose of this study was to formulate evidence-based recommendations on whether to deliver the team-based learning (TBL)-designed clinical pharmacology course at the American University of Beirut Faculty of Medicine (AUBFM) during the third year instead of the fourth and final year of the medical curriculum. Between June 2010 and May 2011, AUBFM offered the course to both classes simultaneously to compare their performance. The findings of this endeavor supported the introduction of the course during the third year, first because fourth-year students did not outperform third-year students despite having the advantage of an additional year of clinical experience, and second, third-year teams seemed more likely to develop into better functioning teams. The findings also suggested that simultaneous delivery of TBL sessions to both third- and fourth-year teams was less favorably recommended because of the varying learning pace of both student groups.
本研究旨在制定循证建议,即是否应在美国贝鲁特美国大学医学院(AUBFM)的医学课程的第三年而不是第四年和最后一年开设以团队为基础的学习(TBL)设计的临床药理学课程。 2010 年 6 月至 2011 年 5 月,AUBFM 同时向两个班级提供该课程,以比较他们的表现。这项工作的结果支持在第三年开设该课程,首先是因为尽管四年级学生具有额外一年的临床经验,但他们的表现并没有优于三年级学生,其次,三年级团队似乎更有可能发展成为更好的团队。研究结果还表明,由于两个学生群体的学习进度不同,同时向三年级和四年级团队提供 TBL 课程不太可取。